Excellence Headquarters™, Management Company for The CORE Institute® and other physician practices, announced that Paul Robinson has accepted the position of Chief Information Officer, providing vision and leadership in all information technology initiatives. In his role, Robinson and his team of programmers and IT architects will direct the planning and implementation of enterprise information technology systems in support of The CORE Institute’s business operations as the orthopedic group continues to grow nationally.

“Paul will play an important role in ensuring that our providers and employees utilize the best technology systems available to provide to our managed practices and their patients with best-in-class care and services,” said Dr. David J. Jacofsky, Chairman and CEO of Excellence Headquarters.  “Adding someone with Paul’s team’s experience and talent to our leadership team demonstrates our commitment to our providers, employees and patients as we continue to pursue our national expansion efforts.

“Excellence Headquarters is a management platform that allows for increased practice performance  and provides integrated IT solutions for management of quality, marketing, evidence-based practice, and at risk contract strategies for its managed practices,” said Robinson. “I am very excited to lead this talented team not only with Excellence Headquarters, but The CORE Institute, and provide technology to best serve our patients.”

Prior to joining Excellence Headquarters, Robinson spent 20+ years in information technology roles, specifically designing and developing software to meet healthcare needs.  Most recently, as Vice President of Product and Software Development at PhDx Systems, he helped in the company becoming the leading provider of clinical data management software and services designed to meet the unique research needs of orthopedic and spine companies. Robinson played an instrumental role in the development of clinical management software for device manufacturers such as Medtronic, Stryker and NuVasive.